Voloridge Investment Management, LLC Immunity Bio, Inc. Transaction History

Voloridge Investment Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $567,124 - $1.02 Million	-100,022 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.17 - $14.24 $365,452 - $567,506	39,853 Added 66.24%	100,022 $974,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $806,866 - $1.35 Million	60,169 New	60,169 $859,000

202

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.8B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.